$100.30 -0.81 (%) Gilead Sciences Inc - NASDAQ

Nov. 26, 2014 | 04:00 PM

Partner Headlines

  1. #PreMarket Primer: Wednesday, November 26: Big Retailers Gear Up For Black Friday

    Benzinga | Nov. 26, 2014 | 08:13AM EST
  2. Can Partnering To Fight Hepatitis C Pay At Entanta?

    IBD | Nov. 24, 2014 | 16:44PM EST
  3. Can Partnering To Fight Hepatitis C Pay At Enanta?

    IBD | Nov. 24, 2014 | 16:44PM EST
  4. AbbVie, Celgene, Sanofi Drugs Get EU Endorsements

    IBD | Nov. 21, 2014 | 12:28PM EST
  5. CNBC's Stock Pops & Drops From November 19

    Benzinga | Nov. 20, 2014 | 07:38AM EST
  6. Screening Pharma Stocks Amid Turnaround

    YCharts | Nov. 19, 2014 | 09:37AM EST
  7. Stock Movers: Why 4 Big Drug Stocks Are Rising Today

    IBD | Nov. 18, 2014 | 14:38PM EST
  8. Incyte Building Blockbuster Drug One Disease At A Time

    IBD | Nov. 17, 2014 | 15:58PM EST
  9. Weekly CFO Sells Highlight: Tableau Software Inc, Gilead Sciences Inc, Facebook Inc.

    GuruFocus | Nov. 16, 2014 | 22:36PM EST
  10. Julian Robertson's Tiger Management 13F Reveals Huge Alibaba Stake

    Benzinga | Nov. 15, 2014 | 09:57AM EST
  11. Biotech Stocks Hit: Stock Market To See New Leaders?

    IBD | Nov. 14, 2014 | 18:22PM EST
  12. CNBC's Stock Pops & Drops From November 13: King Digital, Alibaba, SanDisk, Gilead Sciences

    Benzinga | Nov. 14, 2014 | 07:25AM EST
  13. Gilead Sciences In Correction Mode

    Benzinga | Nov. 13, 2014 | 13:37PM EST
  14. Here Are The Top 25 Analysts On Wall Street

    Benzinga | Nov. 13, 2014 | 10:47AM EST
  15. Momentum Investing By Sub-Sector: 1990 To Now

    YCharts | Nov. 13, 2014 | 04:04AM EST
  16. Fast Money Halftime Report Final Trade From November 12: Twitter, Dunkin Brands, Gilead Sciences

    Benzinga | Nov. 12, 2014 | 15:58PM EST
  17. Gilead Sciences Releases Impressive Results for Hepatitis C Drug

    GuruFocus | Nov. 12, 2014 | 11:56AM EST
  18. #PreMarket Primer: Wednesday, November 12: Banks Fined More Than $3 Billion For Role In Forex Manipulation

    Benzinga | Nov. 12, 2014 | 07:44AM EST
  19. Gilead up on Harvoni results

    IBD | Nov. 11, 2014 | 18:30PM EST
  20. Merck down on hep C data

    IBD | Nov. 10, 2014 | 19:00PM EST
  21. Shire CEO Looks Ahead To Independent Future

    IBD | Nov. 10, 2014 | 16:46PM EST
  22. Stock Movers: Why These 5 Top Stocks Are Rising Today

    IBD | Nov. 10, 2014 | 14:04PM EST
  23. Gilead, Price Controls' Supporting Role in the Midterms

    FoxBusiness | Nov. 10, 2014 | 13:00PM EST
  24. Merck Down On Hepatitis C Data; Gilead Rises

    IBD | Nov. 10, 2014 | 11:14AM EST
  25. RBC Sees Weak Merck Data As Positive For Gilead

    Benzinga | Nov. 10, 2014 | 09:29AM EST
  26. Premarket: Stock Futures Mixed; Gilead Climbs On Merck News

    IBD | Nov. 10, 2014 | 08:59AM EST
  27. Stock Movers: Why Medicals Issues Are Dipping Today

    IBD | Nov. 7, 2014 | 15:26PM EST
  28. Humana Misses On ObamaCare Spending, Hep C Drug Costs

    IBD | Nov. 7, 2014 | 10:32AM EST
  29. Why Gilead Sciences' Bull Run Should Continue

    GuruFocus | Nov. 6, 2014 | 12:51PM EST
  30. Three Attractively Priced Small Cap Biotech Stocks

    GuruFocus | Nov. 5, 2014 | 12:45PM EST
  31. CNBC's Stock Pops & Drops From November 3: GoPro, Gilead Sciences And More

    Benzinga | Nov. 3, 2014 | 20:17PM EST
  32. Earnings Growth Strong As U.S. Trumps World

    IBD | Nov. 3, 2014 | 17:31PM EST
  33. #PreMarket Primer: Monday, November 3: Commercial Space Travel Questioned After Failed Flights

    Benzinga | Nov. 3, 2014 | 07:55AM EST
  34. IBD 50 Caps Impressive 2-Week Rally

    IBD | Oct. 31, 2014 | 18:47PM EST
  35. Fundamentals, Technicals Still Intact At Gilead Sciences

    IBD | Oct. 31, 2014 | 17:36PM EST
  36. AbbVie Beats Q3 Earnings Estimates, Raises Guidance

    IBD | Oct. 31, 2014 | 14:25PM EST
  37. Veeva Systems Flies High On Cloud For Life Sciences

    IBD | Oct. 30, 2014 | 17:31PM EST
  38. Is Gilead Sciences a Worthy Investment?

    GuruFocus | Oct. 30, 2014 | 15:37PM EST
  39. Fast Money Traders Comment On Stocks Making Headlines On Wednesday: Panera Bread, Hershey And More

    Benzinga | Oct. 29, 2014 | 16:15PM EST
  40. Stocks Worsen As Fed Announcement Looms; AmTrust Dives

    IBD | Oct. 29, 2014 | 13:26PM EST
  41. Stocks Stage Mixed Start; Facebook Drags Down Nasdaq

    IBD | Oct. 29, 2014 | 10:31AM EST
  42. #PreMarket Primer: Wednesday, October 29: Fed Likely To End Bond Purchases

    Benzinga | Oct. 29, 2014 | 07:50AM EST
  43. Gilead Earnings Miss Ahead Of New HCV Drug Launches

    IBD | Oct. 28, 2014 | 18:53PM EST
  44. Civitas Buyout Shores Up Acorda's Wall Street Cred

    IBD | Oct. 28, 2014 | 18:27PM EST
  45. Gilead Sciences Reports Softer Sovaldi Revenues

    Benzinga | Oct. 28, 2014 | 17:15PM EST
  46. Video: Facebook, Gilead Post Earnings After The Close

    IBD | Oct. 28, 2014 | 14:00PM EST
  47. Aetna Falls On Costs; Centene Rises On Medicaid Gains

    IBD | Oct. 28, 2014 | 12:38PM EST
  48. Earnings Scheduled For October 28, 2014

    Benzinga | Oct. 28, 2014 | 05:25AM EST
  49. Gilead Rises Ahead Of Q3 Earnings As Rivals Wobble

    IBD | Oct. 27, 2014 | 15:38PM EST
  50. #PreMarket Primer: Monday, October 27: ECB Stress Tests In-Line With Expectations

    Benzinga | Oct. 27, 2014 | 08:19AM EST
Trading Center